Structure Therapeutics Inc.: total assets
Total assets for Structure Therapeutics Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Structure Therapeutics Inc. financial histories
What this measure means
Resources recognized on the balance sheet. Book assets are not the market value of the business.
Exact concept: us-gaap:Assets. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2022-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 1,583,918,000 | USD | 2026-02-26 | 10-K · 0001104659-26-020562 |
| At date | 2024-12-31 | 903,330,000 | USD | 2026-02-26 | 10-K · 0001104659-26-020562 |
| At date | 2023-12-31 | 482,017,000 | USD | 2025-02-27 | 10-K · 0001558370-25-001826 |
| At date | 2022-12-31 | 97,845,000 | USD | 2024-03-08 | 10-K · 0001558370-24-002791 |
Related financial histories
- Structure Therapeutics Inc.: total liabilities
- Structure Therapeutics Inc.: stockholders equity
- Structure Therapeutics Inc.: cash and cash equivalents
- Structure Therapeutics Inc.: net income or loss
- Structure Therapeutics Inc.: operating cash flow
- Structure Therapeutics Inc.: capital expenditure payments
- Structure Therapeutics Inc.: financing cash flow
- Structure Therapeutics Inc.: investing cash flow
- Structure Therapeutics Inc.: retained earnings or deficit
- Structure Therapeutics Inc.: basic weighted-average shares
- Structure Therapeutics Inc.: diluted weighted-average shares
- Structure Therapeutics Inc.: basic earnings per share
- Structure Therapeutics Inc.: diluted earnings per share
- Structure Therapeutics Inc.: income tax expense or benefit
- Structure Therapeutics Inc.: net property, plant and equipment
- Structure Therapeutics Inc.: share-based compensation expense
- Structure Therapeutics Inc.: operating income or loss
- Structure Therapeutics Inc.: current assets
- Structure Therapeutics Inc.: current liabilities
- Structure Therapeutics Inc.: current accounts payable
- Structure Therapeutics Inc.: operating expenses
- Structure Therapeutics Inc.: research and development expense
Inspect the source
- Entity
- Structure Therapeutics Inc. / CIK 0001888886
- Captured
- 2026-09-21T17:33:21.747Z
- SEC response SHA-256
ffd3a7961a303b061b9e637c0a68b38cdae700193db068276e48b97fce881728
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001888886.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))